In Vivo Preclinical Assessment of the VEGF Targeting Potential of the Newly Synthesized [52Mn]Mn-DOTAGA-Bevacizumab Using Experimental Cervix Carcinoma Mouse Model

Absztrakt
Leírás
Kulcsszavak
Forrás
Diagnostics. -13 : 2 (2023), p. 236-. -Diagnostics. - 2075-4418. - 2075-4418